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Case Report
A 75-year-old female with a past medical history significant 
for hypertension, hyperlipidemia, and colon cancer, status post 
colectomy with ileostomy, presented to the Methodist Hospital 
emergency room with muscular low back pain, which began a 
few hours prior, after abruptly bending over. Upon arrival to the 
hospital, she had no other complaints and noted that the back 
pain was starting to resolve without intervention.
In triage, her heart rate was measured at 38 beats per minute 
(BPM) with her other vital signs within normal limits. Her 
electrocardiogram (EKG) was read as a junctional rhythm with 
a rate of about 40 BPM, and a wide-complex QRS with what 
appeared to be a new Right Bundle Branch Block morphology. 
Previous EKGs, including one from less than a year earlier, 
were unremarkable. Basic laboratory studies, which returned 
while the patient was in the ER, revealed a potassium of 7.8 
mmol/L with a creatinine of 1.0 mg/dL. Her other labs were 
unremarkable. 
Her hyperkalemia was initially treated in the ER with calcium 
gluconate, intravenous (IV) insulin, and oral sodium polystyrene 
sulfonate, which resulted in narrowing of her QRS complex 
with return of P-waves. Repeat potassium improved to 5.9 
mmol/L. Despite this initial treatment, repeat EKG within an 
hour redemonstrated QRS complex widening with junctional 
rhythm. Repeat potassium level at this time was 7.2 mmol/L, and 
at this point,the patient was admitted to the medical intensive 
care unit (ICU) for further evaluation and treatment. 
Over the next day, this pattern of fluctuating potassium levels 
along with electrocardiographic changes continued. After 
nearly 24 hours of continued treatment with IV insulin and 
multiple doses of sodium polystyrene sulfonate, her potassium 
levels eventually stabilized to the normal range. Of note, the 
patient never had any subjective complaints, and her creatinine 
never elevated above her baseline level of 1.0 mg/dL. Urinalysis 
was unremarkable and urine electrolytes were significant only 
for mildly elevated urinary potassium. It was confirmed that 
the patient was taking lisinopril 40 mg daily, which had been 
at a stable dose for several years for hypertension. Eventually, 
further questioning done by the patient’s nurse revealed that 
the patient had recently been attempting to improve her health 
by cutting salt out of her diet. In its place, she began using a 
“salt substitute” product, which she thought was healthier. In 
fact, she actually preferred this product to salt, and began using 
a lot of it over the few weeks leading up to her presentation. 
Ultimately, it was felt that her excess dietary potassium intake 
in the form of the salt substitute product lead to high total body 
potassium levels, explaining why it was so difficult to correct 
her hyperkalemia. 
Discussion
Hyperkalemia is a common electrolyte abnormality, which can 
be lethal in severe cases. As such, a high index of suspicion for 
hyperkalemia is needed for patients at high risk or who are found 
to have electrocardiographic changes which are consistent with 
hyperkalemia. This patient’s presentation is unusual in several 
ways, which partly contributed to the delay in her diagnosis. 
First, her physical complaints and her medical background 
were not typical of a patient with severe hyperkalemia. The 
patient population most at risk for severe hyperkalemia are 
those with significant renal disease and who may already be 
dialysis dependent.1 In addition to presenting with arrhythmias, 
hyperkalemia can also present with neuromuscular complaints, 
ranging from weakness to fasciculations, and frequently with 
nonspecific gastrointestinal (GI) complaints such as abdominal 
cramping and vomiting. Although the patient’s initial presenting 
symptom was muscular back pain, the mechanism of her injury 
does not suggest that hyperkalemia played any role. In addition, 
she had no other cardiac or GI complaints.
Second, despite the fact that the patient was taking an 
angiotensin-converting enzyme (ACE)-inhibitor, she appeared 
to have overall normal renal function. Since potassium is 
primarily cleared from the body via the kidney, most cases 
of severe hyperkalemia are seen in patients with a significant 
degree of renal impairment or those who are on medications 
such as ACE-inhibitors, angiotensin II receptor blockers (ARBs) 
or potassium-sparing diuretics, which may affect how efficiently 
potassium is excreted.1,2 In the absence of these predisposing 
factors, it is very unusual for excess intake of dietary potassium 
alone to overwhelm the renal excretion mechanisms and cause 
severe hyperkalemia.3
Third, the patient’s EKG was not initially recognized as 
representing hyperkalemia. Less severe hyperkalemia likely 
would have been recognized based on its characteristic finding 
of sinus rhythm with peaked T-waves. Severe hyperkalemia 
would have been identified based on a sine-wave pattern.2 It 
is important to note the standard progression of electrocar-
diographic changes that occur with progressive hyperkalemia. 
The classic finding of narrow-based, peaked T-waves, which 
are usually best seen in the inferior and mid-precordial leads, 
occur at potassium levels over 5.5 mmol/L, but are only seen 
in a relatively small percentage of those with this mild degree 
of hyperkalemia. At potassium levels beyond 6.5 mmol/L, QRS 
complex widening and PR segment prolongation can occur. At 
levels of 8 to 9 mmol/L, a sinoventricular rhythm may be seen, 
in which the sinoatrial node directly stimulates the ventricles 
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without evidence of atrial activity. This is because the SA node 
is less susceptible to the effects of hyperkalemia than is atrial 
tissue. As such, the P-wave can disappear and the rhythm can 
appear to be junctional or ventricular. At levels over 10 mmol/L, 
the SA node no longer functions, and a junctional or ventricular 
escape takes over the pacemaker function of the heart, eventually 
with the QRS complex blending with the T-wave to form the 
classic sine-wave pattern, which is seen just prior to ventricular 
fibrillation and asystole. This patient’s presenting EKG, which 
showed a wide complex QRS without P-waves at a rate of 40, 
was consistent with more severe hyperkalemia than would be 
predicted by her potassium level of 7.8 mmol/L. One additional 
finding which was useful in making the electrocardiographic 
diagnosis of hyperkalemia was that the QRS widening was 
present throughout the entire complex, rather than just at the 
terminal portion which would be expected with a true Right 
Bundle Branch Block.2
With the large focus that has recently been put on modifiable 
risk factors for cardiovascular disease development, dietary 
sodium intake has become an emerging topic in public health 
and policy, and has received much attention in the media. 
Along with this, salt substitutes, which often are composed of 
potassium chloride, have become more popular and may be 
viewed by the public as a healthy alternative to standard table 
salt. Potassium-based salt substitutes have been noted on many 
occasions to have led to significant hyperkalemia.3 Of particular 
concern is that patients who are on medications such as 
ACE-inhibitors are those who may already have cardiovascular 
disease, renal disease, or diabetes, and therefore would benefit 
greatly from reducing dietary sodium intake. However, this is 
also the population that would be most at risk for significant 
hyperkalemia from excess dietary potassium intake.4 One 
recent study5 suggested that decreasing dietary sodium while 
increasing dietary potassium may result in overall mortality 
benefit. This study was reported on in a recent New York Times 
article,6 touting the benefits of patients improving their sodium 
to potassium intake ratio, but never mentioning that in certain 
populations, this can lead to potentially severe hyperkalemia 
and adverse outcomes. This case emphasizes the importance 
that must be placed on having high clinical suspicion for 
hyperkalemia, especially in the patient population most at risk, 
and of course, the diagnostic value of taking a careful history.
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